Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Psoriatic 1

Interventions

pembrolizumab 284 Carboplatin 216 Cisplatin 148 Paclitaxel 145 Gemcitabine 145 Bevacizumab 117 Pemetrexed 114 Docetaxel 103 Oxaliplatin 79 Cyclophosphamide 79 Dexamethasone 78 durvalumab 77 atezolizumab 77 Fluorouracil 77 Nivolumab 75 130-nm albumin-bound paclitaxel 71 Fulvestrant 68 Capecitabine 64 Injections 63 Cetuximab 63 Leucovorin 60 Rituximab 56 fludarabine 52 Lenalidomide 49 Prednisone 46 venetoclax 43 Irinotecan 43 Letrozole 40 enzalutamide 39 tislelizumab 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × guselkumab × 90 days × Clear all

NCT04936308 2026-06-05

SOLSTICE

Janssen Research & Development, LLC

Phase 3 Active not recruiting

453 enrolled 25 charts

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡